peroxynitrous acid has been researched along with ro13-9904 in 2 studies
| Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (ro13-9904) | Trials (ro13-9904) | Recent Studies (post-2010) (ro13-9904) |
|---|---|---|---|---|---|
| 3,303 | 21 | 1,230 | 6,815 | 798 | 2,755 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, BF; Kastenbauer, S; Koedel, U; Pfister, HW | 1 |
| Kastenbauer, S; Klein, M; Koedel, U; Pfister, HW | 1 |
2 other study(ies) available for peroxynitrous acid and ro13-9904
| Article | Year |
|---|---|
Pneumococcal meningitis in the rat: evaluation of peroxynitrite scavengers for adjunctive therapy.
Topics: Animals; Brain Chemistry; Ceftriaxone; Cephalosporins; Chemokine CXCL2; Chemokines; Cytokines; Free Radical Scavengers; Indicators and Reagents; Interleukin-1; Interleukin-6; Male; Meningitis, Pneumococcal; Monokines; Peroxynitrous Acid; Rats; Rats, Wistar | 2002 |
Meningitis-associated hearing loss: protection by adjunctive antioxidant therapy.
Topics: Acetylcysteine; Animals; Anti-Bacterial Agents; Antioxidants; Audiometry; Ceftriaxone; Cell Count; Cochlea; Disease Models, Animal; Drug Interactions; Evans Blue; Evoked Potentials, Auditory, Brain Stem; Hearing Loss; Labyrinthitis; Male; Meningitis, Pneumococcal; Metalloporphyrins; Peroxynitrous Acid; Rats; Rats, Wistar; Spiral Ganglion; Time Factors | 2003 |